Armistice Capital, Llc

Insider Reports History

Entity
Company
Location
510 Madison Avenue, 7 Th Floor, New York, NY
Signature
ARMISTICE CAPITAL, LLC, Name: /s/ Steven Boyd, Title: Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Armistice Capital, Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ReShape Lifesciences Inc. 10%+ Owner Common Stock 7.22M $39.6M $5.48 Jun 28, 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Common Stock 7.22M $39.6M $5.48 Jun 28, 2021 Indirect
EYEGATE PHARMACEUTICALS INC 10%+ Owner Common Stock 785K $3.01M $3.83 Aug 2, 2021 Indirect
AYTU BIOPHARMA, INC Director Common Stock 1.34M $2.51M $1.87 Mar 29, 2021 Direct
AYTU BIOPHARMA, INC Director Common Stock 1.34M $2.51M $1.87 Mar 29, 2021 Indirect
Avalo Therapeutics, Inc. 10%+ Owner Common Stock 731K $380K $0.52 Jun 27, 2023 Indirect
Avalo Therapeutics, Inc. 10%+ Owner Common Stock 34.4K $17.9K $0.52 Jun 26, 2023 Direct
TENAX THERAPEUTICS, INC. Director Pre-Funded Common Stock Purchase Warrants 10.6M May 18, 2022 Indirect
TENAX THERAPEUTICS, INC. Director Series C Common Stock Purchase Warrants 10.6M May 18, 2022 Indirect
TENAX THERAPEUTICS, INC. Director Warrant (right to buy) 4.77M May 18, 2022 Indirect
TENAX THERAPEUTICS, INC. Director Series B Common Stock Purchase Warrants 3.18M May 18, 2022 Indirect
TENAX THERAPEUTICS, INC. Director Common Stock Purchase Warrants 2.07M May 18, 2022 Indirect
EYEGATE PHARMACEUTICALS INC 10%+ Owner Series C Convertible Preferred Stock 0 Jul 27, 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series A Warrants 0 Jun 28, 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series A Warrants 0 Jun 28, 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series E Warrants 0 Jun 28, 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series E Warrants 0 Jun 28, 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Series G Warrants 0 Jun 28, 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Series G Warrants 0 Jun 28, 2021 Indirect
ReShape Lifesciences Inc. 10%+ Owner Warrant 0 Jun 28, 2021 Direct
ReShape Lifesciences Inc. 10%+ Owner Warrant 0 Jun 28, 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Common Stock 0 Jun 15, 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Common Stock 0 Jun 15, 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series A Warrants 0 Jun 15, 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series A Warrants 0 Jun 15, 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series E Warrants 0 Jun 15, 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series E Warrants 0 Jun 15, 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Series G Warrants 0 Jun 15, 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Series G Warrants 0 Jun 15, 2021 Indirect
ReShape Weightloss Inc. 10%+ Owner Warrant 0 Jun 15, 2021 Direct
ReShape Weightloss Inc. 10%+ Owner Warrant 0 Jun 15, 2021 Indirect

Insider Reports Filed by Armistice Capital, Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTX Avalo Therapeutics, Inc. Jun 26, 2023 2 -$2.17M 4 Jun 28, 2023 10%+ Owner
AVTX Avalo Therapeutics, Inc. Feb 3, 2023 3 $1.32K 4 Feb 9, 2023 10%+ Owner
TENX TENAX THERAPEUTICS, INC. May 18, 2022 12 $0 4 May 19, 2022 Director
AVTX Avalo Therapeutics, Inc. Mar 10, 2022 3 $152K 4 Mar 14, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Mar 3, 2022 3 $344K 4 Mar 7, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Feb 24, 2022 2 $112K 4 Feb 28, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Feb 17, 2022 3 $232K 4 Feb 22, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Jan 18, 2022 3 $274K 4 Jan 20, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Jan 12, 2022 3 $453K 4 Jan 14, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Jan 7, 2022 3 $643K 4 Jan 11, 2022 Director, 10%+ Owner
AVTX Avalo Therapeutics, Inc. Sep 15, 2021 3 $12.6M 4 Sep 17, 2021 Director, 10%+ Owner
AVTX Cerecor Inc. Aug 16, 2021 2 $138K 4 Aug 18, 2021 Director, 10%+ Owner
AVTX Cerecor Inc. Aug 4, 2021 3 $409K 4 Aug 6, 2021 Director, 10%+ Owner
KPRX EYEGATE PHARMACEUTICALS INC Jul 30, 2021 2 -$647K 4 Aug 3, 2021 10%+ Owner
KPRX EYEGATE PHARMACEUTICALS INC Jul 27, 2021 9 -$10.5M 4 Jul 29, 2021 Director, 10%+ Owner
TENX TENAX THERAPEUTICS, INC. Jul 8, 2021 2 $0 4 Jul 9, 2021 Director
RSLS ReShape Lifesciences Inc. Jun 28, 2021 24 $0 4 Jun 29, 2021 10%+ Owner
RSLS ReShape Lifesciences Inc. Jun 16, 2021 12 -$14.2M 4 Jun 22, 2021 10%+ Owner
RSLS ReShape Lifesciences Inc. Jun 15, 2021 0 $0 3 Jun 22, 2021 10%+ Owner
RSLS ReShape Weightloss Inc. Jun 15, 2021 14 $0 4 Jun 22, 2021 10%+ Owner
AVTX Cerecor Inc. May 14, 2021 6 $392K 4 May 18, 2021 Director, 10%+ Owner
AYTU AYTU BIOPHARMA, INC Mar 20, 2021 4 $0 4 May 10, 2021 Director